Mind Medicine Lists on NASDAQ
MNMD becomes the second major high profile billion dollar market cap psychedelic company to list on the NASDAQ.
MNMD becomes the second major high profile billion dollar market cap psychedelic company to list on the NASDAQ.
Rritual Superfoods (CSE: RSF) hit a new all-time high on Friday of $1.15 per share for a gain of 35.29% in only 12 trading days since Psychstocks announced RSF as its latest brand new mushroom pick on March 30th at $0.85 per share!
It was just announced today that Rite Aid will begin to carry the mushroom products of Rritual Superfoods (CSE: RSF) on a nationwide basis!
The first ever psychstock ETF has just begun trading on the Canadian NEO Exchange called Horizons Psychedelic Stock Index ETF (NEO: PSYK).
Our first three Psychstock suggestions have gained an average at their highs of 392.31%!
On the afternoon of December 18th, Psychstocks announced BetterLife Pharma (CSE: BETR) at $1.17 per share as its #1 favorite Psychstock for 2021. BETR closed today at its high of day of $2.25 per share. BETR has already gained by 92.3% in only seven trading days!
Our new #1 favorite Psychstock for 2021 is Betterlife Pharma (CSE: BETR) or BETRF on the U.S. OTCQB. BETR is currently trading for $1.17 per share.
Numinus Wellness (TSXV: NUMI) gained as much as 9.87% today to hit a new all-time high of $2.45 per share for a gain of 807.41% since we profiled it as our #1 favorite Psychstock at $0.27 per share!
Revive Therapeutics (CSE: RVV) gained as much as 76.92% today to hit a new record high of $0.92 per share for a gain of 275.51% since we profiled it as our new #1 favorite Psychstock at $0.245 per share!
Psychstocks founder Gerard Adams considers RVV and NUMI to be the two highest quality small-cap stocks in the psychedelic space and their incredibly strong performance is proving Gerard right!
Numinus Wellness (TSXV: NUMI) had its biggest up day in history on Wednesday gaining by 34.83% to finish at a new all-time high closing price of $1.20 per share.
RVV gained by 29.51% to close at its high of day of $0.395 per share and is now up by 61.22% from our initial profile price.
Psychedelics industry bellwether Compass Pathways (CMPS) gained $6.62 or 16.21% today to finish at a new all-time high closing price of $47.45 per share! We consider Revive Therapeutics (CSE: RVV) to be the #1 highest quality small-cap psychedelic biotech play.
Yesterday morning, NUMI hit a high of $0.53 per share for a gain of 85.96% from our breakout point alert exactly one month ago on the morning of September 28th at $0.285 per share.
Compass Pathways (CMPS) was featured on CNBC today, causing the stock to gain by $4.19 or 12.25% to close at $38.39 per share. Here is a video of the segment.
Psychstocks is extremely excited to announce its new #1 favorite psilocybin biotechnology stock suggestion: Revive Therapeutics (CSE: RVV). Revive also has a U.S. OTC symbol: RVVTF.
Psychstocks is getting ready to announce its #1 favorite psilocybin biotechnology stock suggestion!
Compass Pathways (CMPS) gained by $3.66 or 10.41% yesterday to close at $38.82 per share for its second biggest up day since its IPO less than one month ago.
Our #1 favorite psychstock NUMI is up 10.17% today to a new 3-month high of $0.325 per share!
Following the release of Citron Research’s bullish report on Compass Pathways (CMPS), the stock gained as much as 28.44% to reach a new record high of $47.29 per share, but only finished the day up by 8.91% to $40.10 per share. We believe Andrew Left made a mistake by releasing his report before the open of trading.